Literature DB >> 18938169

Immunoregulation by Toxoplasma gondii infection prevents allergic immune responses in mice.

Angelika Wagner1, Elisabeth Förster-Waldl, Erika Garner-Spitzer, Irma Schabussova, Michael Kundi, Arnold Pollak, Otto Scheiner, Anja Joachim, Ursula Wiedermann.   

Abstract

Toxoplasma gondii is a ubiquitous intracellular parasite affecting most mammals including humans. In epidemiological studies, infection with T. gondii and allergy development have been postulated to be inversely related. Using a mouse model of birch pollen allergy we investigated whether infection with T. gondii influences allergic immune responses to birch pollen. BALB/c mice were infected with T. gondii oocysts either before or at the end of sensitisation with the major birch pollen allergen Bet v 1 and thereafter aerosol challenged with birch pollen extract. During the acute phase of infection, clinical signs correlated with increased levels of serum TNF-alpha, IL-6, IFN-gamma and anti-Toxoplasma-IgM. In the chronic phase, Toxoplasma-specific serum IgG, brain tissue cysts and high IFN-gamma production in spleen cell cultures were detected. Mice infected prior to allergic sensitisation produced significantly less allergen-specific IgE and IgG1, while IgG2a levels were markedly increased. IL-5 levels in spleen cell cultures and bronchoalveolar lavage fluid were significantly reduced, and airway inflammation was prevented in these mice. Notably, in mice infected at the end of the allergic sensitisation process, systemic and local immune responses to the allergen were markedly reduced. T.gondii infection was associated with up-regulation of Toll-like receptor 2 (TLR2), 4, 9 and 11, as well as T-bet (a differentiation factor for Th1 cells) mRNA expression in splenocytes; moreover, enhanced TGF-beta, IL-10 and Foxp3 mRNA expression in these cells suggested that regulatory mechanisms were involved in suppression of the allergic immune response. Kinetic studies confirmed the induction of Foxp3(+)CD4(+)CD25(+) regulatory T cells preferentially during the chronic phase of T. gondii infection. Our data demonstrate that T. gondii exhibits strong immunomodulating properties which lead to prevention of allergic immune responses and thereby support the hygiene hypothesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18938169     DOI: 10.1016/j.ijpara.2008.09.003

Source DB:  PubMed          Journal:  Int J Parasitol        ISSN: 0020-7519            Impact factor:   3.981


  15 in total

1.  Sweet and CRISP(R)y parasite engineering.

Authors:  Iain B H Wilson; Irma Schabussova
Journal:  J Biol Chem       Date:  2019-01-25       Impact factor: 5.157

Review 2.  Murine models for mucosal tolerance in allergy.

Authors:  Ursula Smole; Irma Schabussova; Winfried F Pickl; Ursula Wiedermann
Journal:  Semin Immunol       Date:  2017-08-12       Impact factor: 11.130

Review 3.  Strategies of mucosal immunotherapy for allergic diseases.

Authors:  Yi-Ling Ye; Ya-Hui Chuang; Bor-Luen Chiang
Journal:  Cell Mol Immunol       Date:  2011-06-13       Impact factor: 11.530

4.  IgE mediates killing of intracellular Toxoplasma gondii by human macrophages through CD23-dependent, interleukin-10 sensitive pathway.

Authors:  Ioannis Vouldoukis; Dominique Mazier; Daniel Moynet; Denis Thiolat; Denis Malvy; M Djavad Mossalayi
Journal:  PLoS One       Date:  2011-04-22       Impact factor: 3.240

5.  Toxoplasma gondii infection in the brain inhibits neuronal degeneration and learning and memory impairments in a murine model of Alzheimer's disease.

Authors:  Bong-Kwang Jung; Kyoung-Ho Pyo; Ki Young Shin; Young Sang Hwang; Hyoungsub Lim; Sung Joong Lee; Jung-Ho Moon; Sang Hyung Lee; Yoo-Hun Suh; Jong-Yil Chai; Eun-Hee Shin
Journal:  PLoS One       Date:  2012-03-21       Impact factor: 3.240

6.  Levels of Transforming Growth Factor-Beta After Immunization of Mice With in vivo prepared Toxoplasma gondii Excretory/Secretory Proteins.

Authors:  Seyed Hossein Abdollahi; Fateme Ayoobi; Hossein Khorramdelazad; Behzad Nasiri Ahmadabadi; Mohammadtaghi Rezayati; Mohammad Kazemi Arababadi; Mohammad Zare-Bidaki
Journal:  Jundishapur J Microbiol       Date:  2015-05-31       Impact factor: 0.747

7.  Prime-boost vaccination with toxoplasma lysate antigen, but not with a mixture of recombinant protein antigens, leads to reduction of brain cyst formation in BALB/c mice.

Authors:  Angelika Wagner; Irma Schabussova; Bärbel Ruttkowski; Roman Peschke; Józef Kur; Michael Kundi; Anja Joachim; Ursula Wiedermann
Journal:  PLoS One       Date:  2015-05-26       Impact factor: 3.240

8.  Toxoplasma gondii infection induces suppression in a mouse model of allergic airway inflammation.

Authors:  Ignacio M Fenoy; Romina Chiurazzi; Vanesa R Sánchez; Mariana A Argenziano; Ariadna Soto; Mariano S Picchio; Valentina Martin; Alejandra Goldman
Journal:  PLoS One       Date:  2012-08-28       Impact factor: 3.240

9.  Perinatal maternal administration of Lactobacillus paracasei NCC 2461 prevents allergic inflammation in a mouse model of birch pollen allergy.

Authors:  Irma Schabussova; Karin Hufnagl; Mimi L K Tang; Elisabeth Hoflehner; Angelika Wagner; Gerhard Loupal; Sophie Nutten; Adrian Zuercher; Annick Mercenier; Ursula Wiedermann
Journal:  PLoS One       Date:  2012-07-06       Impact factor: 3.240

10.  Heme oxygenase-1 activity is involved in the control of Toxoplasma gondii infection in the lung of BALB/c and C57BL/6 and in the small intestine of C57BL/6 mice.

Authors:  Ester C B Araujo; Bellisa F Barbosa; Loyane B Coutinho; Paulo V C Barenco; Luciana A Sousa; Cristiane M Milanezi; Giuliano Bonfá; Wander R Pavanelli; João S Silva; Eloisa A V Ferro; Deise A O Silva; Jair P Cunha-Junior; Neide M Silva
Journal:  Vet Res       Date:  2013-10-02       Impact factor: 3.683

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.